Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022

We included 852 patients in a prospectively recruiting multicenter matched case-control study in Germany to assess vaccine effectiveness (VE) in preventing COVID-19-associated hospitalization during the Delta-variant dominance. The two-dose VE was 89 % (95 % CI 84–93 %) overall, 79 % in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Stoliaroff-Pepin, Anna, Peine, Caroline, Herath, Tim, Lachmann, Johannes, Perriat, Delphine, Dörre, Achim, Nitsche, Andreas, Michel, Janine, Grossegesse, Marica, Hofmann, Natalie, Rinner, Thomas, Kohl, Claudia, Brinkmann, Annika, Meyer, Tanja, Dorner, Brigitte G., Stern, Daniel, Treindl, Fridolin, Hein, Sascha, Werel, Laura, Hildt, Eberhard, Gläser, Sven, Schühlen, Helmut, Isner, Caroline, Peric, Alexander, Ghouzi, Ammar, Reichardt, Annette, Janneck, Matthias, Lock, Guntram, Schaade, Lars, Wichmann, Ole, Harder, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715487/
https://www.ncbi.nlm.nih.gov/pubmed/36509640
http://dx.doi.org/10.1016/j.vaccine.2022.11.065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715487/
https://www.ncbi.nlm.nih.gov/pubmed/36509640
http://dx.doi.org/10.1016/j.vaccine.2022.11.065

Ejemplares similares